Profil
Carola Jüstel is currently the Chief Executive Officer & Director at Xpress Biologics SA since 2021.
Prior to this, she was the Chief Executive Officer at Pepscan Holding NV.
From 2017 to 2019, she served as the Chief Executive Officer at Pepscan Therapeutics BV.
Aktive Positionen von Carola Jüstel
| Unternehmen | Position | Beginn |
|---|---|---|
Xpress Biologics SA
 Xpress Biologics SA BiotechnologyHealth Technology Xpress Biologics SA develops and produces bio molecules for medical applications. It engages in design of expression systems, process development and manufacturing of new biologics, biosimilars and biobetters, management of the pre-clinical and clinical trials and management of the GMP manufacturing services. The company was founded by Marc Daukandt, Philippe Ledent and Christian Rodriguez on April 14, 2014 and is headquartered in Milmort, Belgium. | Vorstandsvorsitzender | 01.09.2021 |
Ehemalige bekannte Positionen von Carola Jüstel
| Unternehmen | Position | Ende |
|---|---|---|
Pepscan Therapeutics BV
 Pepscan Therapeutics BV Pharmaceuticals: MajorHealth Technology Pepscan Therapeutics BV develops immunotherapeutic products in oncology. The company was founded in 2000 and is headquartered in Lelystad, the Netherlands. | Vorstandsvorsitzender | 01.01.2019 |
Pepscan Holding NV
 Pepscan Holding NV Pharmaceuticals: MajorHealth Technology Pepscan Holding NV operates as a holding company with interest in developing immunotherapeutic products in oncology. It offers proprietary technologies for the design, manufacture and use of large combinatorial arrays of peptides, peptide constructs, peptidometics and peptide derivatives. The firm operates through its subsidiaries Pepscan Systems BV and Pepscan Therapeutics BV. The company was founded in 2007 and is headquartered in Lelystad, the Netherlands. | Vorstandsvorsitzender | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Pepscan Holding NV
Pepscan Holding NV Pharmaceuticals: MajorHealth Technology Pepscan Holding NV operates as a holding company with interest in developing immunotherapeutic products in oncology. It offers proprietary technologies for the design, manufacture and use of large combinatorial arrays of peptides, peptide constructs, peptidometics and peptide derivatives. The firm operates through its subsidiaries Pepscan Systems BV and Pepscan Therapeutics BV. The company was founded in 2007 and is headquartered in Lelystad, the Netherlands. | Health Technology |
Pepscan Therapeutics BV
Pepscan Therapeutics BV Pharmaceuticals: MajorHealth Technology Pepscan Therapeutics BV develops immunotherapeutic products in oncology. The company was founded in 2000 and is headquartered in Lelystad, the Netherlands. | Health Technology |
Xpress Biologics SA
Xpress Biologics SA BiotechnologyHealth Technology Xpress Biologics SA develops and produces bio molecules for medical applications. It engages in design of expression systems, process development and manufacturing of new biologics, biosimilars and biobetters, management of the pre-clinical and clinical trials and management of the GMP manufacturing services. The company was founded by Marc Daukandt, Philippe Ledent and Christian Rodriguez on April 14, 2014 and is headquartered in Milmort, Belgium. | Health Technology |
